Grier, A., Jang, A., Kumar, H. L., Wu, C. W., Kyasaram, R. K., Sheng, I. Y. F., Mendiratta, P., Garcia, J. A., Barata, P. C., Rao, S., Brown, J. R. (2026). Integrating circulating tumor DNA (ctDNA) and
                    <i>TP53</i>
                    alteration variant allele frequency (VAF) to predict outcomes in advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.815